From the publisher feed

Food and Drug Administration nominee Dr. Heidi Overton committed to a timeline for a delayed mifepristone safety study, Sen. Josh Hawley's office says.

Read the original at Fox News ↗

Opens the original publisher page. Access, copyright and subscriptions are controlled by the publisher.

A useful next step

  1. Read the short publisher description here.
  2. Open the full report directly at the publisher.
  3. Compare this topic with other sources when useful.